Nathan Professor of Pediatrics atDana-Farber Tumor Institute, Children’s Hospital Boston, and Harvard Medical College in Boston. This analysis opens up a fresh avenue for treatment, a way to genetically activate healthy fetal hemoglobin in the red blood cells of sufferers with these lifelong blood disorders. Dr. Jian Xu will show this study in the Plenary Scientific Program on Sunday, December 6, at 3:00 p.m. In Hall F. Hydroxyurea in Children With Sickle Cell Disease: Practice Patterns and Barriers to Utilization [Abstract #242] Sickle cell disease is normally frequently marked by episodes of severe and incapacitating discomfort called vaso-occlusive painful events, that may sometimes require hospitalization.Copyright 2006 Advisory Panel Kaiser and Company Family members Foundation. All rights reserved.. Adding spectroscopy to breast MR examinations may enhance the performance and quality of patient care Measuring the biochemical shifts in breasts tumors with magnetic resonance spectroscopy enables radiologists to more accurately distinguish benign tumors from cancerous types, relating to a study showing up in the August issue of the journal Radiology. Adding spectroscopy to breast MR examinations can not only reduce concern over possible missed cancers and unneeded biopsy procedures, it may also improve the effectiveness and quality of patient care, said co-writer Sina Meisamy, M.D., a postdoctoral fellow at the University of Minnesota Center for Magnetic Resonance Study in Minneapolis.